These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15239160)

  • 1. An "ACE" in the hole for fixing atrial fibrillation?
    Health News; 2004 Jul; 10(7):11. PubMed ID: 15239160
    [No Abstract]   [Full Text] [Related]  

  • 2. [The therapeutic efficiency of complex-ACE inhibitor (perindopril) and traditional antiarrhythmic-treatment for prevention atrial fibrillation paroxysms after successful electric cardio version].
    Abuladze GV; Dzhindzholiia NR; Narsiia EV; Dzhincharadze BZ; Kadzhaia TZ
    Georgian Med News; 2008 Feb; (155):17-9. PubMed ID: 18401049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of suppressing the renin-angiotensin system on atrial fibrillation.
    Kalus JS; Coleman CI; White CM
    J Clin Pharmacol; 2006 Jan; 46(1):21-8. PubMed ID: 16397280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic management of atrial fibrillation in patients with late-stage CKD.
    Aronow WS
    Am J Kidney Dis; 2009 Apr; 53(4):701-10. PubMed ID: 19324248
    [No Abstract]   [Full Text] [Related]  

  • 5. Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart.
    Fazio G; Pizzuto C; Sutera L; Guttilla D; Di Gesaro G; Cascio C; Novo G; Assennato P; Novo S
    Minerva Cardioangiol; 2007 Jun; 55(3):311-5. PubMed ID: 17534249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation: new theories, emerging treatments.
    Johnson J; Napier KT
    JAAPA; 2005 Jun; 18(6):36-41; quiz 43-4. PubMed ID: 15977854
    [No Abstract]   [Full Text] [Related]  

  • 7. Electrical cardioversion for AF-the state of the art.
    Gall NP; Murgatroyd FD
    Pacing Clin Electrophysiol; 2007 Apr; 30(4):554-67. PubMed ID: 17437583
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic aims for atrial fibrillation in patients with heart failure].
    Lewalter T; Nitschmann S
    Internist (Berl); 2009 Jan; 50(1):101-3. PubMed ID: 19137270
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug Insight: angiotensin-converting-enzyme inhibitors and atrial fibrillation--indications and contraindications.
    Lévy S
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):220-5. PubMed ID: 16568131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
    Shelton R
    Eur Heart J; 2004 Dec; 25(23):2174; author reply 2174-5. PubMed ID: 15571844
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trials, the renin angiotensin system and atrial fibrillation.
    Birnie DH; Gollob M; Healey JS
    Curr Opin Cardiol; 2006 Jul; 21(4):368-75. PubMed ID: 16755207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation and congestive heart failure.
    Bourke T; Boyle NG
    Minerva Med; 2009 Apr; 100(2):137-43. PubMed ID: 19390499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM; Sanoski CA; Spinler SA
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Innovative therapeutic approach to atrial fibrillation: AT1-receptor blocker].
    Goette A
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35 Suppl 4):S103-7. PubMed ID: 16921445
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling.
    Healey JS; Morillo CA; Connolly SJ
    Curr Opin Cardiol; 2005 Jan; 20(1):31-7. PubMed ID: 15596957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
    Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
    Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug treatment of atrial fibrillation].
    Janko S; Hoffmann E
    MMW Fortschr Med; 2006 Apr; 148(15):32-5. PubMed ID: 16711199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors: a new therapy for atrial fibrillation?
    Al-Khatib SM
    Am Heart J; 2004 May; 147(5):751-2. PubMed ID: 15131524
    [No Abstract]   [Full Text] [Related]  

  • 19. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation.
    Casaclang-Verzosa G; Gersh BJ; Tsang TS
    J Am Coll Cardiol; 2008 Jan; 51(1):1-11. PubMed ID: 18174029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amiodarone treatment on outcome after direct current cardioversion in atrial fibrillation: should we cardiovert atrial fibrillation of longer duration.
    Agarwal SC; Pepper CB
    Int J Cardiol; 2007 May; 117(3):406-7. PubMed ID: 16904207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.